CIK 0001681682 · Non-accelerated filer<br>Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260579295
- Phone
- 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- 4 Open-market buy Director bought 20,000 shares at $0.26 ($5,200)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- DEFA14A Proxy Proxy Materials
- 4 Open-market buy Chief Technology Officer bought 25,000 shares at $0.21 ($5,250)
- 4 Open-market buy Chief Technology Officer bought 25,000 shares at $0.22 ($5,500)
- 4 Open-market buy Chief Executive Officer bought 5,100 shares at $0.19 ($969)
- 4 Open-market buy Director bought 100,000 shares at $0.20 ($19,630)
- DEFA14A Proxy Proxy Materials
- 10-Q Report Quarterly Report
- 25-NSE Other Notification of Removal from Listing
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 11 of 28 · 547 filings